Skip to main content
E

EBOS GROUP LIMITED — Investor Relations & Filings

Ticker · EBO ISIN · NZEBOE0001S6 LEI · 254900KJ40C7HBYTWC21 ASX Wholesale and retail trade
Filings indexed 1,246 across all filing types
Latest filing 2026-05-01 Regulatory Filings
Country AU Australia
Listing ASX EBO

About EBOS GROUP LIMITED

https://www.ebosgroup.com

EBOS Group Limited is a marketer, wholesaler, and distributor of healthcare, medical, and pharmaceutical products, alongside a portfolio of animal care brands and services. The organization operates through two primary divisions: Healthcare and Animal Care. The Healthcare segment encompasses pharmacy wholesaling, hospital supplies, and contract logistics, supporting a network of pharmacies and medical providers through the distribution of specialized medicines and medical devices. It also oversees retail pharmacy franchising and support services. The Animal Care segment focuses on the marketing and distribution of premium pet food, health products, and veterinary supplies to clinics and retail outlets. The company utilizes an integrated supply chain infrastructure to facilitate the delivery of essential health and wellness products, maintaining a diversified presence across human and animal health sectors.

Recent filings

Filing Released Lang Actions
Performance Rights Update
Regulatory Filings
2026-05-01 English
Investor Day Presentation
Investor Presentation Classification · 1% confidence The document is titled “Investor Day Presentation” and contains detailed slide content: disclaimers, agenda, strategy, financial frameworks, segment analyses, and non-GAAP metrics. This is a full investor presentation rather than a brief earnings release or simple announcement of a report. It aligns with category 17: Investor Presentation (IP).
2026-04-29 English
Advance Notice - Investor Day
Investor Presentation Classification · 1% confidence The document is a market release announcing EBOS Group’s Investor Day event and webcast details, with supporting presentation materials to be lodged and made available for investors. It is not a financial or regulatory report, but an invitation and details for an investor presentation. This aligns with the Investor Presentation category.
2026-04-28 English
Performance Rights Update
Share Issue/Capital Change Classification · 1% confidence The document is a brief announcement lodged with the NZX/ASX detailing a change in the company’s equity instruments – specifically the lapse of performance rights and updated rights on issue. It is not a full report, earnings release, or director trade, but rather a notification of a capital structure change. This fits under the “Share Issue/Capital Change” category (SHA).
2026-04-27 English
Impact of elevated fuel costs on FY26 earnings outlook
Regulatory Filings Classification · 1% confidence The document is a market release by EBOS Group Limited on NZX/ASX providing an update to FY26 earnings outlook driven by elevated fuel and energy costs. It does not present full financial results or detailed financial statements (so it is not an Interim/Quarterly Report or Annual Report), nor is it a dividend notice, management change, M&A, or financing update. It is a regulatory announcement of guidance updates and therefore best fits the fallback category of a general Regulatory Filing (RNS).
2026-04-21 English
Capital Change Notice - Employee Share Plan
Share Issue/Capital Change Classification · 1% confidence The document is an official NZX Capital Change Notice detailing the issuance of 5,553 ordinary shares under the EBOS Employee Share Plan, including issuer details, number of shares issued, price, authority, and date. This is a clear announcement of a share issue/capital change. According to the classification definitions, such announcements fall under “Share Issue/Capital Change” (Code: SHA).
2026-04-17 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.